Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase). | Kirk Jensen

Jensen KDC, Sercarz E, Raja-Gabaglia C. Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase). Molecular Immunology. 2009;(46(3):366–374.

See also: Master’s thesis at the La Jolla Institute for Allergy and Immunology

Publisher's Version

Last updated on 07/28/2022